You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

gastric cancer advanced gastric or metastatic gastric cancer PI3K PIK3CA mutation Her2 amplification HSP90 inhibitor PI3K inhibitor PIK3CA amplification

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Endometrial Cancer, Ovarian Cancer Trial in Houston (Copanlisib, fulvestrant)

Recruiting
  • Endometrial Cancer
  • Ovarian Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Sep 27, 2022

PIK3CA Mutation-Related Tumors Trial in Shanghai (WX390)

Completed
  • PIK3CA Mutation-Related Tumors
  • Shanghai, Shanghai, China
    Shanghai East Hospital
Nov 9, 2023

HER2-positive Breast Cancer Trial (Inavolisib, PHESGO, Endocrine therapy)

Not yet recruiting
  • HER2-positive Breast Cancer
  • (no location specified)
Mar 23, 2022

PIK3CA Mutation, Solid Tumor, Adult, HER2-negative Breast Cancer Trial (RLY-5836, Fulvestrant, Palbociclib)

Not yet recruiting
  • PIK3CA Mutation
  • +7 more
  • (no location specified)
Mar 7, 2023

Stomach Tumors Esophageal Tumors Metastatic Gastric Cancer Mutated PI3KCA Protein Overexpressed HER2 Protein Trial in Worldwide

Completed
  • Stomach Neoplasms Esophageal Neoplasms Metastatic Gastric Cancer Mutated PI3KCA Protein Overexpressed HER2 Protein
  • Boston, Massachusetts
  • +8 more
Dec 6, 2020

Breast Cancer Trial (Inavolisib, Fulvestrant, Alpelisib)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
Jan 30, 2023

Metastatic Breast Cancer, Advanced Breast Cancer, HR-positive Breast Cancer Trial (OP-1250, Ribociclib, Alpelisib)

Not yet recruiting
  • Metastatic Breast Cancer
  • +3 more
  • (no location specified)
Aug 18, 2022

HR+/HER2-negative Breast Cancer, Metastatic Breast Cancer Trial (Evexomostat)

Not yet recruiting
  • HR+/HER2-negative Breast Cancer
  • Metastatic Breast Cancer
  • (no location specified)
Jul 7, 2022

Anatomic Stage IV Breast Cancer AJCC v8, HER2-Positive Breast Carcinoma, Metastatic Breast Carcinoma Trial in United States

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +2 more
  • Los Angeles, California
  • +4 more
Jul 19, 2022

Colorectal Cancer, Gastric Cancer, HER2-negative Breast Cancer Trial (TOS-358)

Not yet recruiting
  • Colorectal Cancer
  • +8 more
  • (no location specified)
Jan 5, 2023

Slow-Flow Vascular Malformation, Fast-Flow Vascular Malformation, Vascular Malformations Trial in Parkville (Alpelisib,

Not yet recruiting
  • Slow-Flow Vascular Malformation
  • +17 more
  • Parkville, Victoria, Australia
    The Royal Children's Hospital
Aug 7, 2023

Breast Cancer Trial in United States (Benralizumab, fulvestrant or AIs) and PI3K inhibition (alpelisib))

Recruiting
  • Breast Cancer
  • Benralizumab
  • fulvestrant or AIs) and PI3K inhibition (alpelisib)
  • Stanford, California
  • +8 more
Aug 1, 2023

Advanced Gastric Adenocarcinoma Trial in Seoul (GSK2636771, Paclitaxel)

Completed
  • Advanced Gastric Adenocarcinoma
  • Seoul, Korea, Republic of
    Severance Hospital, Yonsei University Health System, Yonsei Canc
Apr 21, 2021

Advanced or Metastatic Breast Cancer, ER+ve Advanced or Metastatic Breast Cancer Trial in Worldwide (AZD5363 when combined with

Completed
Has Results
  • Advanced or Metastatic Breast Cancer
  • ER+ve Advanced or Metastatic Breast Cancer
  • AZD5363 when combined with weekly paclitaxel.
  • +2 more
  • Plovdiv, Bulgaria
  • +40 more
Dec 23, 2022

Salivary Gland Cancer, Metastatic, Advanced Trial in Toronto (Selinexor, EGFR or HER2 Inhibitor, FGFR Inhibitor)

Recruiting
  • Salivary Gland Cancer
  • +3 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Feb 18, 2022

Advanced or Metastatic Breast Cancer Trial in Worldwide (MEN1611, Trastuzumab, Fulvestrant)

Active, not recruiting
  • Advanced or Metastatic Breast Cancer
  • Fort Lauderdale, Florida
  • +26 more
Feb 14, 2022

Metastatic Colorectal Cancer Trial in Worldwide (MEN1611, Cetuximab)

Recruiting
  • Metastatic Colorectal Cancer
  • Phoenix, Arizona
  • +26 more
Feb 14, 2022

Breast Cancer Trial in Italy (Ribociclib, Letrozole, Alpelisib)

Active, not recruiting
  • Breast Cancer
  • Casale Monferrato, AL, Italy
  • +40 more
Dec 3, 2021

Breast Cancer Trial in Worldwide (Inavolisib, Placebo, Palbociclib)

Recruiting
  • Breast Cancer
  • Tucson, Arizona
  • +228 more
Jan 10, 2023

Advanced Gastric Cancer Trial in Seoul (AZD5363, paclitaxel)

Completed
  • Advanced Gastric Cancer
  • Seoul, Seoul, Korea, Republic Of, Korea, Republic of
    Samsung Medical Center
Dec 26, 2019

Endometrial Endometrioid Adenocarcinoma, Endometrial Mixed Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma Trial in

Completed
Has Results
  • Endometrial Endometrioid Adenocarcinoma
  • +5 more
  • New Haven, Connecticut
  • +42 more
Jan 25, 2022

Advanced Breast Cancer Trial in Thalassery (Alpelisib, Fulvestrant)

Recruiting
  • Advanced Breast Cancer
  • Thalassery, Kerala, India
    Novartis Investigative Site
Nov 21, 2022

HNSCC Trial in United States (Tipifarnib, Alpelisib)

Recruiting
  • HNSCC
  • Duarte, California
  • +10 more
Jun 30, 2022

Metastatic Breast Cancer Trial in East Melbourne (BYl719)

Completed
  • Metastatic Breast Cancer
  • East Melbourne, Victoria, Australia
    Peter MacCallum Cancer Centre
Aug 11, 2022

HER2-positive Breast Cancer Trial in Rome (PIK3CA analysis)

Active, not recruiting
  • HER2-positive Breast Cancer
  • PIK3CA analysis
  • Rome, RM, Italy
    Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Feb 20, 2023